Il-15 superagonist and dinutuximab significantly enhance expanded natural killer cell activity against Gd2+ pediatric solid tumors (ST)

Authors

Y Chu
G Nayyar
J Rosenblum
J Lyngdoh
J Cao
Salomon Amar, Touro College
M. S. Cairo

Publication Date

2019

DOI

10.1002/pbc.27713

Recommended Citation

Chu, Y., Nayyar, G., Rosenblum, J., Lyngdoh, J., Cao, J., Amar, S., & Cairo, M. S. (2019). Il-15 superagonist and dinutuximab significantly enhance expanded natural killer cell activity against Gd2+ pediatric solid tumors (ST). Pediatric Blood & Cancer, 66(S2), 1026. https://doi.org/10.1002/pbc.27713